Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Changkyu Gu

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Science Translational Medicine|September 20, 2023
The D2D3 form of uPAR acts as an immunotoxin and may cause diabetes and kidney diseaseKe Zhu, Kamalika Mukherjee, Changli Wei, et al.
The Journal of Biological Chemistry|November 7, 2013
Transient receptor potential channel 6 (TRPC6) protects podocytes during complement-mediated glomerular diseaseAndreas D Kistler, Geetika Singh, Mehmet M Altintas, et al.
Nature Communications|May 3, 2022
Simultaneous stabilization of actin cytoskeleton in multiple nephron-specific cells protects the kidney from diverse injuryKamalika Mukherjee, Changkyu Gu, Agnieszka Collins, et al.
Nature Medicine|May 12, 2015
Pharmacological targeting of actin-dependent dynamin oligomerization ameliorates chronic kidney disease in diverse animal modelsMario Schiffer, Beina Teng, Changkyu Gu, et al.
The Journal of Clinical Investigation|September 14, 2011
CD2AP in mouse and human podocytes controls a proteolytic program that regulates cytoskeletal structure and cellular survivalSuma Yaddanapudi, Mehmet M Altintas, Andreas D Kistler, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Science Translational Medicine|September 20, 2023
The D2D3 form of uPAR acts as an immunotoxin and may cause diabetes and kidney diseaseKe Zhu, Kamalika Mukherjee, Changli Wei, et al.
The Journal of Biological Chemistry|November 7, 2013
Transient receptor potential channel 6 (TRPC6) protects podocytes during complement-mediated glomerular diseaseAndreas D Kistler, Geetika Singh, Mehmet M Altintas, et al.
Nature Communications|May 3, 2022
Simultaneous stabilization of actin cytoskeleton in multiple nephron-specific cells protects the kidney from diverse injuryKamalika Mukherjee, Changkyu Gu, Agnieszka Collins, et al.
Nature Medicine|May 12, 2015
Pharmacological targeting of actin-dependent dynamin oligomerization ameliorates chronic kidney disease in diverse animal modelsMario Schiffer, Beina Teng, Changkyu Gu, et al.
The Journal of Clinical Investigation|September 14, 2011
CD2AP in mouse and human podocytes controls a proteolytic program that regulates cytoskeletal structure and cellular survivalSuma Yaddanapudi, Mehmet M Altintas, Andreas D Kistler, et al.
Pageof 2